Glenn Tate Insider Profile
4 Followers
Glenn Tate, Senior Officer at Medexus Pharmaceuticals Inc, holds 71.12K shares in Medexus Pharmaceuticals Inc (Ticker: TSE:MDP). Most recently, Glenn Tate Bought 10,000 shares of Medexus Pharmaceuticals Inc on Sep 22, 2022 for an estimated value of C$11.90K.
Glenn Tate's Trading History
| MDPMedexus Pharmaceuticals Inc | Sep 22, 2022 | Senior Officer | Informative Buy | 11.90K | C$386.16K | |||||||||||||||||||||||||||||||||||||||||||
TSE:MDP Insider Shares: 71.12K (35.65%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Glenn Tate insider profile FAQ
What is the percentage of profitable transactions made by Glenn Tate?
The percentage of profitable transactions made by Glenn Tate is 20%.
What is the average return per transaction made by Glenn Tate?
The average return per transaction made by Glenn Tate is -4.50%.
What stocks does Glenn Tate hold?
Glenn Tate holds: TSE:MDP stocks.
What was Glenn Tate’s latest transaction?
Glenn Tate’s latest transaction was an Informative Buy of C$11.90K.
What was Glenn Tate's most profitable transaction?
Glenn Tate’s most profitable transaction was an Informative Buy of TSE:MDP stock on September 22, 2022. The return on the trade was 181.80%.
What is Glenn Tate's role in Medexus Pharmaceuticals Inc?
Glenn Tate's role in Medexus Pharmaceuticals Inc is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
